USPTO serial 87429367
ARENDIS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CROWLEY, SEAN MICHAEL
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ARENDIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
431 83 Mölndal, SE
431 83 Mölndal, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel L. Scales
DANIEL L. SCALES CHOATE HALL & STEWART LLPTWO INTERNATIONAL PLACEBOSTON, MA 02110UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Compilation of business data being medical reports in the field of pharmaceuticals development | ACTIVE | — |
| 042 | Conducting of clinical research for others; conducting clinical trials for others; conducting of clinical trials for pharmaceutical products; development and provision of medical and scientific research information and reports relating to drugs and clinical tests; conducting of scientific method studies relating to medical imaging; drug discovery services relating to medical imaging; Research and development relating to medical imaging for the pharmaceutical and biotechnology industries; scientific investigations for medical development and medical purposes; Writing of computer programs for medical applications with focus on medical imaging; clinical research relating to medical imaging; medical research relating to medical imaging; scientific research with focus on medical imaging; advisory services relating to scientific research with a focus on medical imaging and pharmaceuticals development; development of testing methods relating to medical imaging; research and development services in the field of medical imaging; scientific research and analysis in the field of pharmaceuticals development; Services for the development of testing methods relating to medical imaging; pharmaceutical research and development relating to medical imaging; design and development of medical imaging technology; design and development of medical diagnostic apparatus relating to medical imaging; design and development of computer software for use with medical technology with focus on medical imaging; science and technology services in the field of medical imaging; scientific services being engineering services and research and design relating thereto in the field of medical imaging; X-ray services within the field of pharmaceuticals development being not for medical purposes and for scientific research purposes only; X-ray technician services in the field of pharmaceuticals development being not for medical purposes and for scientific research purposes only; advisory services relating to medical services in the field of pharmaceuticals development | ACTIVE | — |
| 044 | X-ray services; X-ray technician services; medical evaluation services in the field of pharmaceuticals development; medical imaging services in the field of pharmaceuticals development; advisory services relating to medical services in the field of pharmaceuticals development; compilation of medical records in the field of pharmaceuticals development; conducting medical examinations in the field of pharmaceuticals development; x-ray examinations for medical purposes in the field of pharmaceuticals development; medical diagnostic, analysis and testing services in the field of pharmaceuticals development; preparation of reports relating to medical matters in the field of pharmaceuticals development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Antaros Medical AB
- Other trademarks owned by Antaros Medical AB
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ARENDIS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 8, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 8, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 7, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 5, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 5, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 5, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 12, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 10, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 10, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 10, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 8, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 6, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 6, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 6, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 8, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 13, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 13, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 3, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 3, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 3, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 2, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jan 24, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 3, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2017 | NWAP | NEW APPLICATION ENTERED | — |